Is Wockhardt Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Wockhardt Ltd (WOCKPHARMA.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Wockhardt Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Wockhardt Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Wockhardt Ltd?

Muslim investors may consider investing in Wockhardt Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Wockhardt Ltd classified as HALAL?

Musaffa determines the Shariah status of Wockhardt Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Wockhardt Ltd updated?

The Shariah compliance status of Wockhardt Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Wockhardt Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Wockhardt Ltd?

You can check the latest Shariah compliance status of Wockhardt Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

WOCKPHARMA.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 14, 2026

Report Source: 2026 3rd Quarter Report

Wockhardt Ltd. Stock Analysis WOCKPHARMA.NS

India Health Care Mid Cap Report: Q3, 2026

Wockhardt Ltd. engages in the pharmaceutical business. The company is headquartered in Mumbai, Maharashtra and currently employs 2,296 full-time employees. The firm is engaged in the pharmaceutical business. The company focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. The company manufactures and supplies branded and generic finished formulations, as well as intermediate products like active pharmaceutical ingredients (APIs), worldwide. The Company’s products in India include EMROK, MERIWOK, REINVEXIN, ERLISO, METHYCOBAL 500 MCG 15T, METHYCOBAL INJ 1 ML, METHYCOBAL D 10T, HAPID 10C, PROXYFEN NANO GEL, LIVATIRA 500 10T NEW PACK, LIVATIRA INJ 5 ml, GABAWOK NT 100MG 15T, GABAWOK NT 400MG 15T, ETOBRIX 90 MG 10C, ETOBRIX TH 4 10C, ETOBRIX P 10T, GLARZEN 100IU, TERITIDE, GLIMADAY HS, GLIMADAY FORTE-2, GLIMADAY FORTE-1, GLIMADAY FORTE 3, GLIMADAY 2 mg, GLIMADAY 1 mg, MOPADAY FORTE, INOGLA, WEPOX 4000 IU 1ML, MYCORAL M, Val 450, OKERON INJ 100MCG 1ML, DARBOTIN 40, and DARBOTIN 60.

Key Statistics of Wockhardt Ltd (WOCKPHARMA.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹1,500.10₹1,603.90

Today's Open

₹1,400.00

Volume

459.69K

P/E Ratio (TTM)

52 Week Range

₹1,086.70₹1,868.80

Market Cap

232.22B

Avg. Volume

1.39M

Dividend Yield

Financial Metrics & Statements of Wockhardt Ltd (WOCKPHARMA.NS)

FAQ's for Wockhardt Ltd (WOCKPHARMA.NS)

According to Musaffa’s Shariah screening methodology, Wockhardt Ltd (WOCKPHARMA.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.